-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AGQ9n4ZtJ22tTqL1dq5wbfLoxGJq33fAJUuME84cDoIyjFfqjL/tqULToO7ul7nB D44QSXggTJpSN4Ru/VHvcg== 0001230295-08-000009.txt : 20080104 0001230295-08-000009.hdr.sgml : 20080104 20080104164855 ACCESSION NUMBER: 0001230295-08-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080102 FILED AS OF DATE: 20080104 DATE AS OF CHANGE: 20080104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOROWITZ ZEBULUN D CENTRAL INDEX KEY: 0001225436 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 08512312 BUSINESS ADDRESS: STREET 1: 70 WOOD AVE S CITY: ISELIN STATE: NJ ZIP: 08830 BUSINESS PHONE: 9086328800 4 1 hor286.xml X0202 4 2008-01-02 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001225436 HOROWITZ ZEBULUN D C/O SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER BLVD., 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 SVP, Chief Medical Officer Common Stock, $.01 par value per share 2008-01-02 4 M 0 5000 2.5200 A 138078 D Common Stock, $.01 par value per share 2008-01-02 4 S 0 5000 23.4681 D 133078 D Common Stock, $.01 par value per share 2008-01-03 4 M 0 5000 2.5200 A 138078 D Common Stock, $.01 par value per share 2008-01-03 4 S 0 5000 24.2453 D 133078 D Common Stock, $.01 par value per share 2008-01-04 4 M 0 5000 2.5200 A 138078 D Common Stock, $.01 par value per share 2008-01-04 4 S 0 5000 23.2640 D 133078 D Option to Purchase Common Stock, $.01 par value 2.5200 2008-01-02 4 M 0 5000 2.5200 D 2004-03-24 2013-03-24 Common Stock, $.01 par value per share 5000 70000 D Option to Purchase Common Stock, $.01 par value 2.5200 2008-01-03 4 M 0 5000 2.5200 D 2004-03-24 2013-03-24 Common Stock, $.01 par value per share 5000 65000 D Option to Purchase Common Stock, $.01 par value 2.5200 2008-01-04 4 M 0 5000 2.5200 D 2004-03-24 2013-03-24 Common Stock, $.01 par value per share 5000 60000 D This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934. Represents the average sale price. The highest price at which shares were sold was $23.9401 and the lowest price at which shares were sold was $23.24. Represents the average sale price. The highest price at which shares were sold was $23.81 and the lowest price at which shares were sold was $23.0301. By: /s/ Irina Azer as Attorney-In-Fact for 2008-01-04 -----END PRIVACY-ENHANCED MESSAGE-----